Research Article

Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study

Table 2

Changes in central retinal thickness and best-corrected visual acuity in the whole cohort.

Loading phase (monthly injection)Maintenance phase (PRN regimen)
Baseline1 mo2 mo3 mo4 mo5 mo6 mo7 mo8 mo9 mo10 mo11 mo12 mo

CRT (μm, )
value0.0210.0280.0140.0140.0110.0420.0220.0100.0100.0360.1680.012
BCVA (LogMAR, )
value0.5540.5100.1860.0390.0490.2820.1530.3130.0610.3690.0880.028

Statistically significant difference (), compared with preoperative values in repeated measures ANOVA. CRT: central retinal thickness; BCVA: best-corrected visual acuity; PRN: pro re nata; SD: standard deviation; mo: month.